AU1760201A - Methods for treatment of human huntington's disease and methods of screening foractive agents - Google Patents

Methods for treatment of human huntington's disease and methods of screening foractive agents

Info

Publication number
AU1760201A
AU1760201A AU17602/01A AU1760201A AU1760201A AU 1760201 A AU1760201 A AU 1760201A AU 17602/01 A AU17602/01 A AU 17602/01A AU 1760201 A AU1760201 A AU 1760201A AU 1760201 A AU1760201 A AU 1760201A
Authority
AU
Australia
Prior art keywords
methods
foractive
screening
disease
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17602/01A
Inventor
Ruth Luthi-Carter
James M Olson
Andrew Strand
Anne Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Fred Hutchinson Cancer Center
Original Assignee
General Hospital Corp
Fred Hutchinson Cancer Research Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp, Fred Hutchinson Cancer Research Center filed Critical General Hospital Corp
Publication of AU1760201A publication Critical patent/AU1760201A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU17602/01A 1999-11-12 2000-11-10 Methods for treatment of human huntington's disease and methods of screening foractive agents Abandoned AU1760201A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16507999P 1999-11-12 1999-11-12
US60165079 1999-11-12
PCT/US2000/030900 WO2001034633A2 (en) 1999-11-12 2000-11-10 Methods for treatment of human huntington's disease and methods of screening for active agents

Publications (1)

Publication Number Publication Date
AU1760201A true AU1760201A (en) 2001-06-06

Family

ID=22597330

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17602/01A Abandoned AU1760201A (en) 1999-11-12 2000-11-10 Methods for treatment of human huntington's disease and methods of screening foractive agents

Country Status (2)

Country Link
AU (1) AU1760201A (en)
WO (1) WO2001034633A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002364889A1 (en) * 2001-09-24 2003-06-10 University Of Aarhus Methods for diagnosis and treatment of diseases associated with altered expression of nrf2
US20080027031A1 (en) * 2006-03-08 2008-01-31 Kinemed, Inc. Retinoids and Related Compounds for the Treatment of Neuroinflammatory Conditions, Diseases and Disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5880153A (en) * 1995-11-13 1999-03-09 Spinal Cord Society Method for upregulation of TRKB and TRKC receptors in central nervous system neurons
FR2747041B1 (en) * 1996-04-05 1998-05-22 Cird Galderma USE OF BENZONAPHTHALENIC DERIVATIVES FOR THE MANUFACTURE OF MEDICINES FOR THE TREATMENT OF NEUROPATHIES
WO1999006060A1 (en) * 1997-08-04 1999-02-11 The Regents Of The University Of California Methods for treating neurological deficits

Also Published As

Publication number Publication date
WO2001034633A2 (en) 2001-05-17
WO2001034633A3 (en) 2002-01-10

Similar Documents

Publication Publication Date Title
CY2018020I1 (en) TREATMENT OF ROMRE'S DISEASE
AU2001249835A1 (en) Diagnosis and treatment of alzheimer's disease
HUP0102951A3 (en) Apparatus for treatment of meniere's disease and similar conditions
AU5036198A (en) Methods and devices for collection of soft tissue
AU4054297A (en) Manipulations of nitrosative and oxidatives stress in the treatment of disease
AU3683800A (en) Device for the therapeutic and cosmetic photo-processing of biological tissues and method for using the same
EP1129217A4 (en) Compositions and methods of disease diagnosis and therapy
AU7748000A (en) Method and composition for the treatment of dermatologic diseases
AP2001002102A0 (en) Pharmaceutical agents for the treatment of parkinson's disease and adhd and microadenomas
EP1011644A4 (en) Methods and apparatus for treatment of parkinson's disease
IL137429A0 (en) Methods and compsitions for treating diseases and conditions of the eye
AU5774699A (en) Human stearoyl-coa desaturase-related compositions and methods for treating skin disorders
AU2002222108A1 (en) Diagnosis and treatment of alzheimer's disease
AU4946699A (en) Method of treating meniere's disease and corresponding apparatus
PL336760A1 (en) Treatment of skin diseases
AU5550800A (en) Diagnosis and treatment of alzheimer's disease
HUP0201966A2 (en) Methods of treatment and drug screening methods
ZA971607B (en) Methods of treatment of allergic diseases
AU1760201A (en) Methods for treatment of human huntington's disease and methods of screening foractive agents
EP1173189A4 (en) Asialocytokines and treatment of liver disease
EP1107778A4 (en) Treatment of disease states
GB9908059D0 (en) Diagnosis and treatment of diseases
AU4841296A (en) Diagnosis of and compositions and methods for the treatment of disease
AU1931895A (en) Treatment of graft-versus-host disease
AU5821298A (en) Methods and compositions for screening of human borna disease virus

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase